Woodline Partners’s TScan Therapeutics TCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-115,866
| Closed | -$352K | – | 1028 |
|
|
2024
Q4 | $352K | Buy |
115,866
+7,282
| +7% | +$22.1K | ﹤0.01% | 873 |
|
|
2024
Q3 | $541K | Sell |
108,584
-54,908
| -34% | -$273K | ﹤0.01% | 531 |
|
|
2024
Q2 | $956K | Buy |
+163,492
| New | +$956K | 0.01% | 461 |
|
|
2022
Q4 | – | Sell |
-66,601
| Closed | -$203K | – | 841 |
|
|
2022
Q3 | $203K | Sell |
66,601
-65,716
| -50% | -$200K | ﹤0.01% | 648 |
|
|
2022
Q2 | $416K | Sell |
132,317
-4,613
| -3% | -$14.5K | 0.01% | 581 |
|
|
2022
Q1 | $383K | Buy |
136,930
+37,030
| +37% | +$104K | 0.01% | 524 |
|
|
2021
Q4 | $450K | Buy |
+99,900
| New | +$450K | 0.01% | 558 |
|